Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy

Thrombosis disease has been the leading cause of morbidity and mortality worldwide. In the discovery of antithrombotic agents, three complexes of Cu(2+) and repetitive arginine-glycine-aspartic acid (RGD) sequences, Cu(II)-Arg-Gly-Asp-Ser-Arg-Gly-Asp-Ser (Cu[II]-4a), Cu(II)-Arg-Gly-Asp-Val-Arg-Gly-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jianhui, Wang, Yuji, Wang, Yaonan, Zhao, Ming, Zhang, Xiaoyi, Gui, Lin, Zhao, Shurui, Zhu, Haimei, Zhao, Jinghua, Peng, Shiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404989/
https://www.ncbi.nlm.nih.gov/pubmed/25931819
http://dx.doi.org/10.2147/IJN.S76691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404989/
https://www.ncbi.nlm.nih.gov/pubmed/25931819
http://dx.doi.org/10.2147/IJN.S76691

Ejemplares similares